192 related articles for article (PubMed ID: 16896012)
1. Imatinib and pregnancy.
Ali R; Ozkalemkas F; Ozcelik T; Ozkocaman V; Ozkan A
J Clin Oncol; 2006 Aug; 24(23):3812-3; author reply 3813. PubMed ID: 16896012
[No Abstract] [Full Text] [Related]
2. Pregnancy among patients with chronic myeloid leukemia treated with imatinib.
Ault P; Kantarjian H; O'Brien S; Faderl S; Beran M; Rios MB; Koller C; Giles F; Keating M; Talpaz M; Cortes J
J Clin Oncol; 2006 Mar; 24(7):1204-8. PubMed ID: 16446320
[TBL] [Abstract][Full Text] [Related]
3. Is imatinib safe during pregnancy?
Dolai TK; Bhargava R; Mahapatra M; Mishra P; Seth T; Pati HP; Saxena R
Leuk Res; 2009 Apr; 33(4):572-3. PubMed ID: 18789526
[No Abstract] [Full Text] [Related]
4. Primary ovarian insufficiency associated with imatinib therapy.
Christopoulos C; Dimakopoulou V; Rotas E
N Engl J Med; 2008 Mar; 358(10):1079-80. PubMed ID: 18322295
[No Abstract] [Full Text] [Related]
5. Does early imatinib-induced myelosuppression predict hematologic responses in patients with advanced-phase chronic myeloid leukemia?
Cashen A; DiPersio JF; Khoury H
J Clin Oncol; 2003 Nov; 21(22):4255-6. PubMed ID: 14615462
[No Abstract] [Full Text] [Related]
6. Cutaneous reactions to STI571.
Brouard M; Saurat JH
N Engl J Med; 2001 Aug; 345(8):618-9. PubMed ID: 11529225
[No Abstract] [Full Text] [Related]
7. Imatinib mesylate induced skin hypopigmentation.
Talwar V; Doval DC; Bhatia K
J Assoc Physicians India; 2007 Jul; 55():527. PubMed ID: 17907508
[No Abstract] [Full Text] [Related]
8. Pregnancy under treatment of imatinib and successful labor in a patient with chronic myelogenous leukemia (CML). Outcome of discontinuation of imatinib therapy after achieving a molecular remission.
Ali R; Ozkalemkaş F; Ozçelik T; Ozkocaman V; Ozan U; Kimya Y; Köksal N; Gülten T; Yakut T; Tunali A
Leuk Res; 2005 Aug; 29(8):971-3. PubMed ID: 15978950
[TBL] [Abstract][Full Text] [Related]
9. Exacerbation of psoriasis in a chronic myelogenous leukemia patient treated with imatinib.
Woo SM; Huh CH; Park KC; Youn SW
J Dermatol; 2007 Oct; 34(10):724-6. PubMed ID: 17908148
[No Abstract] [Full Text] [Related]
10. Imatinib-induced erythrodermia in a patient with chronic myeloid leukemia.
Oztas P; Erbasi S; Lenk N; Polat M; Han O; Artuz F; Alli N
Acta Derm Venereol; 2006; 86(2):174-5. PubMed ID: 16648930
[No Abstract] [Full Text] [Related]
11. Vitiligo-like lesions in an adult patient treated with Imatinib mesylate.
Cerchione C; Fabbricini R; Pane F; Luciano L
Leuk Res; 2009 Aug; 33(8):e104-5. PubMed ID: 19232719
[No Abstract] [Full Text] [Related]
12. Partial fanconi syndrome induced by imatinib therapy: a novel cause of urinary phosphate loss.
François H; Coppo P; Hayman JP; Fouqueray B; Mougenot B; Ronco P
Am J Kidney Dis; 2008 Feb; 51(2):298-301. PubMed ID: 18215707
[TBL] [Abstract][Full Text] [Related]
13. Imatinib-related bone marrow aplasia after complete cytogenetic response in chronic myeloid leukemia.
Khan KA; Junaid A; Siddiqui NS; Mukhtar K; Siddiqui S
J Coll Physicians Surg Pak; 2008 Mar; 18(3):176-8. PubMed ID: 18460249
[TBL] [Abstract][Full Text] [Related]
14. Pleural-pericardic effusion as uncommon complication in CML patients treated with Imatinib.
Breccia M; D'Elia GM; D'Andrea M; Latagliata R; Alimena G
Eur J Haematol; 2005 Jan; 74(1):89-90. PubMed ID: 15613116
[No Abstract] [Full Text] [Related]
15. Tumour lysis syndrome with acute renal failure during imatinib therapy.
Ali R; Ozkalemkas F; Ozkan A; Ozcelik T; Ozkocaman V; Akdag I; Ozan U; Tunali A
Leuk Res; 2007 Apr; 31(4):573-4. PubMed ID: 16782190
[No Abstract] [Full Text] [Related]
16. Peritoneal tuberculosis after imatinib therapy.
Senn L; Kovacsovics T; Tarr PE; Meylan P
Arch Intern Med; 2009 Feb; 169(3):312-3. PubMed ID: 19204223
[No Abstract] [Full Text] [Related]
17. Second-generation tyrosine kinase inhibitors in chronic myelogenous leukemia: before or after imatinib?
Tefferi A
Cancer; 2011 Jan; 117(2):234-7. PubMed ID: 21210471
[No Abstract] [Full Text] [Related]
18. [Overcoming imatinib resistance].
Ashihara E; Maekawa T
Nihon Rinsho; 2007 Jan; 65 Suppl 1():399-403. PubMed ID: 17474437
[No Abstract] [Full Text] [Related]
19. Imatinib in pregnancy.
AlKindi S; Dennison D; Pathare A
Eur J Haematol; 2005 Jun; 74(6):535-7. PubMed ID: 15876261
[No Abstract] [Full Text] [Related]
20. Imatinib-induced erythroderma mediated by an unusual non-dose-dependent mechanism.
Vano-Galvan S; Fernandez-Guarino M; Henriquez-Santana A; De Las Heras E; Calbacho M; Jaen P
Eur J Dermatol; 2007; 17(6):538-9. PubMed ID: 17951138
[No Abstract] [Full Text] [Related]
[Next] [New Search]
